Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

House Passes Bioshield Bill; President to Sign It into Law

July 19, 2004 | A version of this story appeared in Volume 82, Issue 29

The House passed Project Bioshield legislation (H.R. 2122) that will make $5.6 billion available over 10 years to purchase and stockpile vaccines and drugs for use against biological weapons. The Senate approved the bill in May, and President George W. Bush is expected to sign it into law. Bush had proposed the legislation in his 2003 State of the Union address as a way to bolster U.S. defenses against biological terrorism. The guaranteed stream of nearly $6 billion is intended to encourage private companies to invest in the costly and time-consuming research and development of vaccines and antidotes. The bill also gives the government added discretionary powers: Federal acquisition procedures for some vaccines and drugs could be eased, and the FDA approval process could be expedited or circumvented if the government deems it necessary.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.